Skip to main content
. 2016 Mar 22;7:312. doi: 10.3389/fmicb.2016.00312

Table 3.

Cytokine levels in recombinant proteins and SLD stimulated PBMCs from treated VL patients (T) and healthy contacts (HC).

S. No. Treatment groups Th1 cytokines
Th2 cytokines
IL-12 IFN-γ TNF-α IL-4 IL-10 TGF-β
1 SLD (T) 530.8 (75.88); (320.1–741.5) 127.2 (16.23); (88.82–165.6) 603.6 (63.66); (453.1–754.2) 206.5 (61.25); (61.64–351.3) 287.1 (66.57); (129.7–444.6) 2567 (460.7); (1478–3656)
2 SLD (HC) 170.9 (72.35); (-29.98–371.8) 105.0 (21.77); (44.54–165.4) 157.4 (67.49); (-30.01–344.8) 225.1 (9.752); (198.0–252.2) 44.95 (17.11); (-2.55–92.44) 2191 (291.4); (1382–3000)
3 p45 (T) 833.5 (139.5); (503.5–1163) 281.7 (70.30); (115.5–447.9) 360.3 (104.3); (113.7–606.8) 204.7 (55.81); (72.67–336.6) 322 (32.76); (244.5–399.4) 2758 (387); (1843–3673)
4 p45 (HC) 214.4 (117.9); (-112.9–541.6) 502.0 (162.0); (52.35–951.7) 204.4 (65.67); (22.04–386.7) 234.3 (18.25); (183.7–285.0) 23.33 (6.862); (4.275–42.38) 2314 (376.7); (1268–3360)
5 Eno (T) 668.6 (162.4); (284.7–1053) 226.4 (36.63); (139.8–313.0) 734.2 (206.5); (245.9–1222) 161.8 (37.02); (74.26–249.3) 304.3 (42.8); (203.1–405.5) 2712 (403.8); (1757–3666)
6 Eno (HC) 492.1 (156.3); (58.18–926.1) 435.9 (161.2); (-11.65–883.4) 193.4 (43.43); (72.84–314.0) 197.8 (24.88); (128.7–266.9) 42.49 (9.393); (16.41–68.57) 2773 (263.6); (2042–3505)
7 Aldo (T) 1389 (131.2); (1079–1699) 284.6 (88.65); (74.97–494.2) 769.0 (224.2); (238.9–1299) 208.0 (43.50); (105.1–310.8) 294.1 (33.08); (215.9–372.3) 3278 (170.9); (2873–3682)
8 Aldo (HC) 165.4 (24.46); (97.46–233.3) 328.0 (106.2); (33.24–622.7) 405.5 (99.87); (128.2–682.7) 271.5 (21.41); (212.0–330.9) 39.13 (7.734); (17.66–60.6) 2698 (590); (1060–4336)
9 TPI (T) 621.4 (119.2); (339.6–903.2) 301.7 (60.08); (159.6–443.7) 724.9 (164.9); (334.9–1115) 190.9 (57.15); (55.71–326.0) 253.6 (26.93); (189.9–317.3) 2547 (457.4); (1465–3629)
10 TPI (HC) 210.9 (84.67); (-24.15–446.0) 241.1 (52.63); (95.0–387.3) 289.1 (63.22); (113.5–464.6) 239.8 (11.78); (207.0–272.5) 26.15 (4.724); (13.03–39.26) 2733 (786.2); (550.5–4916)
11 PDI (T) 644.9 (46.05); (536.0–753.8) 386.9 (100.3); (149.7–624.1) 886.5 (249.3); (297–1476) 191.0 (54.32); (62.55–319.5) 265.7 (42.08); (166.2–365.1) 2679 (415.8); (1695–3662)
12 PDI (HC) 185.4 (76.55); (-27.16–397.9) 340.6 (93.41); (81.21–599.9) 200.3 (55.16); (47.10–353.4) 222.0 (17.58); (173.2–270.8) 50.4 (12.18); (16.59–84.21) 1705 (160); (1260–2149)
13 elF-2 (T) 571.0 (116.3); (296.0–846.0) 310.4 (82.51); (115.3–505.5) 837.6 (204.3); (354.5–1321) 228.5 (67.02); (69.97–386.9) 272.7 (34.27); (191.7–353.8) 2515 (490.7); (1355–3675)
14 elF-2 (HC) 204.8 (98.27); (-68.03–477.7) 370.3 (160.4); (-75.09–815.6) 321.4 (90.38); (70.43–572.3) 222.9 (9.96); (195.2–250.5) 32.91 (8.252); (9.998–55.82) 3818 (1125); (695.6–6940)

Values are displayed as mean (SE); (95% confidence interval).